| |||||||
Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Background Strain NOD Donor Strain (129X1/SvJ x 129S1/Sv)F1-Kitl+ H2 Haplotype g7 Generation N20F?+N1F4pN1 Donating Investigator H. Dosch, University of Toronto Appearance
pink-eyed, albino
Related Genotype: A/? Tyrc/TyrcDescription
Ica1tm1Mdos homozygous mice are viable, fertile, normal in size, and do not display any gross physical or behavioral abnormalities. There is no detectable expression of Ica1 by western blot analysis. Ica1tm1Mdos homozygous animals develop mild salivary gland infiltrations with progression of disease 55%-65% slower than progression of submandibular gland monouclear foci in wildtype and heterozygote controls. Dacryodenitis was undetectable in 35-40 week old male Ica1tm1Mdos homozygous mice compared to 64% of wildtype and 58% of heterozygotes similarly aged (Winer et al., 2002). Development of spontaneous diabetes is slightly delayed in this stock (by 4 weeks) and incidence is modestly diminished (65% incidence in females after 36 weeks versus 85% in wild-type NOD females). Ica1tm1Mdos homozygous females are significantly protected from cyclophosphomide (CY) induced diabetes (10% in females post CY treatment versus 70% incidence in female heterozygote controls). Many unmanipulated Ica1tm1Mdos homozygous females not diagnosed as diabetic died unexpectedly of unknown causes, resulting in a 35% death rate by 50 weeks of age (Winer et al., 2002).This model provides a tool for studying the role of Ica1 as a beta cell autoantigen in the NOD mouse model of Type 1 diabetes and sialadenitis and dacryoadenitis.
Development
A construct containing a tTA-neo cassette replaced the Tep69 epitope of exon 2 region of Islet cell antigen 1,Ica1, commonly referred to as Ica69 and cloned from a 129/Sv mouse genomic library and transfected into R1 ((129X1/SvJ x 129S1/Sv)F1-Kitl+) embryonic stem cells (ES cells). These ES cells were injected into NOD/Lt blastocysts. To establish a colony with germ line transmission, chimeric mice were backcrossed to NOD/Lt. In 2004, The Jackson Laboratory received NOD.129-Ica1tm1Mdos/MdosJ at generation N20. These animals were subsequently backcrossed once to NOD/LtJ prior to intercrossing.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 001976 NOD/ShiLtJ | ||
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Ica1
005082 NOD/ShiLt-Tg(ACTB-Ica1/EGFP)18Mdos/MdosJ View Strains carrying other alleles of Ica1 (1 strain)
Congenic Nomenclature
Genetic Quality Control Annual Report
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Diabetes and Obesity Research
Type 1 Diabetes (IDDM)
Immunology and Inflammation Research
Autoimmunity (Type 1 Diabetes)
| Allele Symbol | Ica1tm1Mdos | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, H Michael Dosch | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | ICA69null; | ||
| Mutation Made By | H. Dosch, University of Toronto | ||
| Strain of Origin | (129X1/SvJ x 129S1/Sv)F1-Kitl+ | ||
| ES Cell Line Name | R1 | ||
| ES Cell Line Strain | (129X1/SvJ x 129S1/Sv)F1-Kitl<+> | ||
| Gene Symbol and Name | Ica1, islet cell autoantigen 1 | ||
| Chromosome | 6 | ||
| Gene Common Name(s) | 69kDa; ICA69; ICAp69; | ||
| Molecular Note | The gene was disrupted by insertion of a tTA-neo cassette into the Tep69 epitope sequence of exon 2 via homologous recombination. Absence of gene expression in homozygous mutant animals was confirmed by Western blot analysis of brain and salivary gland proteins. [MGI Ref ID J:83526] | ||
Genotyping Protocols
Ica1tm1Mdos, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Winer S; Astsaturov I; Gaedigk R; Hammond-McKibben D; Pilon M; Song A; Kubiak V; Karges W; Arpaia E; McKerlie C; Zucker P; Singh B; Dosch HM. 2002. ICA69(null) nonobese diabetic mice develop diabetes, but resist disease acceleration by cyclophosphamide. J Immunol 168(1):475-82. [PubMed: 11751995] [MGI Ref ID J:83526]
Colony Maintenance
Breeding & Husbandry Females homozygote for the targeted mutation at The Jackson Laboratory have fertility issues. Recommended breeding scheme is heterozygote x heterozygote or heterozygote female x homozygote male.
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 001976 NOD/ShiLtJ | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.